Rout in bond market leaves few unscathed, even conservative target dates.
Panelists at <i>IN</i> Alternatives Conference say advisers must do extra due diligence on liquid alternatives.
King Pharmaceuticals-Pfizer deal led to nearly $500,000 in illegal profits, agency claims.
Currently hot, net lease sector could cool off quickly if interest rates rise.
REIT king holding fourth "liquidity event" in two years for one of his nontraded REITs, pushing his enterprise's pro-forma value up near $10 billion.
How traditional investment managers are looking at environmental, social and governance practices to identify top-performing companies
Largest funds have done best since crisis, but market timing hurt performance
Live from the <i>IN</i> Alternatives Conference: 'You always need to understand what you're purchasing'
Hedge-fund managers from Stanley Druckenmiller to Fortress Investment Group LLC's Michael Novogratz and Passport Capital LLC's John Burbank said U.S. stocks will continue to do well this year even as the Federal Reserve gradually reduces its asset purchases.
Study by Harold Evensky finds that belief is more sales pitch than reality.
The group of employees who have charged Fidelity with forcing them into costly proprietary funds in their profit-sharing plan just got a little bigger. That's a big deal.
Long-term prospects of energy infrastructure assets remains attractive, Eagle Global Advisors' David Chiaro says
Live from the <i>IN</i> Alternatives Investments Conference: Low rates, economic uncertainty and surprises have pushed asset classes in the same direction
Demand for new Treasuries from their biggest owners is proving impervious to rising yields and the retreat of Wall Street dealers.
Live from the <i>InvestmentNews</i> Alternatives Investments Conference, the debate rages on over how much investors should be putting into alts. What do you consider the perfect percentage?
Study suggests strategy is no panacea for down markets.
